Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe LM Hofstra, N Sauvageot, J Albert, I Alexiev, F Garcia, D Struck, ... Clinical infectious diseases 62 (5), 655-663, 2016 | 189 | 2016 |
Early alterations of the innate and adaptive immune statuses in sepsis according to the type of underlying infection C Gogos, A Kotsaki, A Pelekanou, G Giannikopoulos, I Vaki, P Maravitsa, ... Critical Care 14, 1-12, 2010 | 170 | 2010 |
Evaluation of a rapid antigen detection test in the diagnosis of streptococcal pharyngitis in children and its impact on antibiotic prescription HC Maltezou, V Tsagris, A Antoniadou, L Galani, C Douros, I Katsarolis, ... Journal of antimicrobial Chemotherapy 62 (6), 1407-1412, 2008 | 132 | 2008 |
Compassionate use of remdesivir in children with severe COVID-19 DL Goldman, ML Aldrich, SHF Hagmann, A Bamford, ... Pediatrics 147 (5), 2021 | 94 | 2021 |
The impact of the heptavalent pneumococcal conjugate vaccine on the epidemiology of acute otitis media complicated by otorrhea K Stamboulidis, D Chatzaki, G Poulakou, S Ioannidou, E Lebessi, ... The Pediatric infectious disease journal 30 (7), 551-555, 2011 | 83 | 2011 |
Septic arthritis due to Salmonella enteritidis associated with infliximab use I Katsarolis, S Tsiodras, P Panagopoulos, E Giannitsioti, G Skarantavos, ... Scandinavian journal of infectious diseases 37 (4), 304-306, 2005 | 64 | 2005 |
Idiopathic sclerosing encapsulating peritonitis (or abdominal cocoon) C Serafimidis, I Katsarolis, S Vernadakis, G Rallis, G Giannopoulos, ... BMC surgery 6, 1-4, 2006 | 61 | 2006 |
Acute uncomplicated cystitis: from surveillance data to a rationale for empirical treatment I Katsarolis, G Poulakou, S Athanasia, J Kourea-Kremastinou, N Lambri, ... International journal of antimicrobial agents 35 (1), 62-67, 2010 | 55 | 2010 |
Mecillinam/clavulanate combination: a possible option for the treatment of community-acquired uncomplicated urinary tract infections caused by extended-spectrum β-lactamase … N Lampri, I Galani, G Poulakou, I Katsarolis, G Petrikkos, H Giamarellou, ... Journal of antimicrobial chemotherapy 67 (10), 2424-2428, 2012 | 49 | 2012 |
Nationwide surveillance of Streptococcus pneumoniae in Greece: patterns of resistance and serotype epidemiology G Poulakou, I Katsarolis, I Matthaiopoulou, S Tsiodras, S Kanavaki, ... International journal of antimicrobial agents 30 (1), 87-92, 2007 | 49 | 2007 |
Risk factors for nasopharyngeal carriage of drug-resistant Streptococcus pneumoniae: data from a nation-wide surveillance study in Greece I Katsarolis, G Poulakou, A Analitis, I Matthaiopoulou, E Roilides, ... BMC Infectious Diseases 9, 1-10, 2009 | 43 | 2009 |
Promoting prudent use of antibiotics: the experience from a multifaceted regional campaign in Greece D Plachouras, A Antoniadou, E Giannitsioti, L Galani, I Katsarolis, ... BMC public health 14, 1-7, 2014 | 42 | 2014 |
Reduction of environmental contamination with multidrug-resistant bacteria by copper-alloy coating of surfaces in a highly endemic setting M Souli, A Antoniadou, I Katsarolis, I Mavrou, E Paramythiotou, ... infection control & hospital epidemiology 38 (7), 765-771, 2017 | 26 | 2017 |
Cefditoren: Comparative efficacy with other antimicrobials and risk factors for resistance in clinical isolates causing UTIs in outpatients D Hatzaki, G Poulakou, I Katsarolis, N Lambri, M Souli, I Deliolanis, ... BMC Infectious Diseases 12, 1-10, 2012 | 18 | 2012 |
Severe dysphagia as the presenting symptom of Wernicke-Korsakoff syndrome in a non-alcoholic man I Karaiskos, I Katsarolis, L Stefanis Neurological Sciences 29, 45-46, 2008 | 16 | 2008 |
Fluoroquinolone treatment of chronic bacterial prostatitis: a prospective cohort study P Panagopoulos, A Antoniadou, K Kanellakopoulou, S Tsiodras, ... Journal of Chemotherapy 21 (3), 317-321, 2009 | 14 | 2009 |
Evidence of less severe aortic valve destruction after treatment of experimental staphylococcal endocarditis with vancomycin and dexamethasone P Siaperas, A Pefanis, D Iliopoulos, I Katsarolis, A Kyroudi-Voulgari, ... Antimicrobial agents and chemotherapy 45 (12), 3531-3537, 2001 | 14 | 2001 |
A switch to Raltegravir improves antiretroviral associated hepatotoxicity in individuals co-infected with HIV and hepatitis C M Cevik, I Katsarolis, GJ Singh, M Nelson Journal of Infection 69 (2), 190-193, 2014 | 13 | 2014 |
Efficacy and safety of an anti-retroviral combination regimen including either efavirenz or lopinavir–ritonavir with a backbone of two nucleoside reverse transcriptase inhibitors P Panagopoulos, S Tsiodras, A Antoniadou, I Katsarolis, A Papadopoulos, ... Clinical microbiology and infection 12 (5), 486-489, 2006 | 13 | 2006 |
Estimation of the determinants for HIV late presentation using the traditional definition and molecular clock‐inferred dates: Evidence that older age, heterosexual risk group … EG Kostaki, S Limnaios, G Adamis, G Xylomenos, M Chini, N Mangafas, ... HIV medicine 23 (11), 1143-1152, 2022 | 12 | 2022 |